{
    "nctId": "NCT05146297",
    "briefTitle": "Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials",
    "officialTitle": "Diversity and Inclusion in Research Underpinning Trials",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Liver Cancer, Prostate Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 1200,
    "primaryOutcomeMeasure": "Change in Clinical Trial Accrual",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* All patients \\>21 years of age with invasive breast, lung or liver cancer, who face a treatment decision\n* patients of doctors who have consented to participate\n* able to give consent and speak either English or Spanish\n* For provider recruitment, oncologists, and advanced practitioners caring for patients with breast, lung, liver cancer including medical and surgical oncologists, interventional radiologists \\& hepatologists will be eligible\n\nExclusion Criteria:\n\n* Patients who are unable to give consent\n* unable to understand English or Spanish\n* lack of invasive breast/liver cancer\n* those who do not face an imminent treatment decision",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}